12 patents
Utility
Tebipenem Pivoxil Crystalline Forms, Compositions Including the Same, Methods of Manufacture, and Methods of Use
19 Oct 23
The disclosure is directed to new crystalline tebipenem pivoxil salt forms, including a crystalline tebipenem pivoxil ethane sulfonate salt form (Form A), a crystalline tebipenem pivoxil ketoglutarate salt form (Form A), tebipenem pivoxil maleate salt forms (Form A and Form B), a tebipenem pivoxil malate salt form (Form A), a tebipenem pivoxil methane sulfonate salt form (Form B), a tebipenem pivoxil hydrobromide salt form (Form B), and a tebipenem pivoxil edisylate salt form (Form A).
Akash JAIN, Evan HECKER, Richard EDWARDS, Thierry BONNAUD
Filed: 9 Jun 23
Utility
Polymyxin Derivatives and Their Use In Combination Therapy Together with Different Antibiotics
12 Oct 23
Pamela BROWN, Michael DAWSON, Mona SIMONOVIC, Steven BOAKES, Esther DUPERCHY, Steven James STANWAY, Antoinette WILSON, Stephen Frederick MOSS
Filed: 24 Mar 23
Utility
Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use
8 Aug 23
The disclosure is directed to new crystalline tebipenem pivoxil salt forms, including a crystalline tebipenem pivoxil ethane sulfonate salt form (Form A), a crystalline tebipenem pivoxil ketoglutarate salt form (Form A), tebipenem pivoxil maleate salt forms (Form A and Form B), a tebipenem pivoxil malate salt form (Form A), a tebipenem pivoxil methane sulfonate salt form (Form B), a tebipenem pivoxil hydrobromide salt form (Form B), and a tebipenem pivoxil edisylate salt form (Form A).
Akash Jain, Evan Hecker, Richard Edwards, Thierry Bonnaud
Filed: 29 Dec 20
Utility
Compounds
12 Jan 23
Pamela BROWN, Michael DAWSON, Mona SIMONOVIC, Steven BOAKES, Esther DUPERCHY, Dean RIVERS, Roy LESTER, Scott COLEMAN
Filed: 23 Aug 22
Utility
Polymyxin compounds
4 Oct 22
Pamela Brown, Michael Dawson, Mona Simonovic, Steven Boakes, Esther Duperchy, Dean Rivers, Roy Lester, Scott Coleman
Filed: 25 Jun 19
Utility
High Dosage Tebipenem Pivoxil Tablet Formulation
12 May 22
The disclosure provides a tebipenem pivoxil HBr formulation in the form of a tablet core comprising at least 70% (w/w) tebipenem pivoxil HBr, and in certain embodiment more than 80% (w/w) tebipenem pivoxil HBr.
Akash JAIN, Ching-Kuo Jim CHOW
Filed: 12 Nov 21
Utility
Compounds
12 Aug 21
Pamela BROWN, Michael DAWSON, Mona SIMONOVIC, Steven BOAKES, Esther DUPERCHY, Dean RIVERS, Roy LESTER, Scott COLEMAN
Filed: 25 Jun 19
Utility
Polymyxin Derivatives and Their Use In Combination Therapy Together with Different Antibiotics
22 Jul 21
Pamela BROWN, Michael DAWSON, Mona SIMONOVIC, Steven BOAKES, Esther DUPERCHY, Steven James STANWAY, Antoinette WILSON, Stephen Frederick MOSS
Filed: 25 Jan 21
Utility
Tebipenem Pivoxil Crystalline Forms, Compositions Including the Same, Methods of Manufacture, and Methods of Use
29 Apr 21
The disclosure is directed to new crystalline tebipenem pivoxil salt forms, including a crystalline tebipenem pivoxil ethane sulfonate salt form (Form A), a crystalline tebipenem pivoxil ketoglutarate salt form (Form A), tebipenem pivoxil maleate salt forms (Form A and Form B), a tebipenem pivoxil malate salt form (Form A), a tebipenem pivoxil methane sulfonate salt form (Form B), a tebipenem pivoxil hydrobromide salt form (Form B), and a tebipenem pivoxil edisylate salt form (Form A).
Akash JAIN, Evan HECKER, Richard EDWARDS, Thierry BONNAUD
Filed: 29 Dec 20
Utility
Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use
12 Jan 21
The disclosure is directed to new crystalline tebipenem pivoxil salt forms, including a crystalline tebipenem pivoxil ethane sulfonate salt form (Form A), a crystalline tebipenem pivoxil ketoglutarate salt form (Form A), tebipenem pivoxil maleate salt forms (Form A and Form B), a tebipenem pivoxil malate salt form (Form A), a tebipenem pivoxil methane sulfonate salt form (Form B), a tebipenem pivoxil hydrobromide salt form (Form B), and a tebipenem pivoxil edisylate salt form (Form A).
Akash Jain, Evan Hecker, Richard Edwards, Thierry Bonnaud
Filed: 6 Feb 18
Utility
Tebipenem Pivoxil Crystalline Forms, Compositions Including the Same, Methods of Manufacture, and Methods of Use
19 Feb 20
The disclosure is directed to new crystalline tebipenem pivoxil salt forms, including a crystalline tebipenem pivoxil ethane sulfonate salt form (Form A), a crystalline tebipenem pivoxil ketoglutarate salt form (Form A), tebipenem pivoxil maleate salt forms (Form A and Form B), a tebipenem pivoxil malate salt form (Form A), a tebipenem pivoxil methane sulfonate salt form (Form B), a tebipenem pivoxil hydrobromide salt form (Form B), and a tebipenem pivoxil edisylate salt form (Form A).
Akash JAIN, Evan HECKER, Richard EDWARDS, Thierry BONNAUD
Filed: 5 Feb 18
Utility
Novel Tebipenem Pivoxil Immediate and Modified Release Oral Dosage Forms
15 Jan 20
Immediate and modified release oral dosage forms of tebipenem pivoxil including dosage form cores are provided.
Akash JAIN, Enxian LU, Shaoqiong LYU, Shoufeng LI, Timothy KEUTZER, Luke UTLEY, Grayzyna FRACZKIEWICZ, Joyce MACWAN
Filed: 14 Dec 17
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first